Genes and mutations causing retinitis pigmentosa. Clin Genet

Department of Ophthalmology and Visual Science, School of Medicine, The University of Texas Health Science Center, Houston, TX 77030, USA.
Archives of Ophthalmology (Impact Factor: 4.49). 03/2007; 125(2):151-8. DOI: 10.1001/archopht.125.2.151
Source: PubMed

ABSTRACT Exceptional progress has been made during the past two decades in identifying genes causing inherited retinal diseases such as retinitis pigmentosa. An inescapable consequence is that the relationship between genes, mutations, and clinical findings has become very complex. Success in identifying the causes of inherited retinal diseases has many implications, including a better understanding of the biological basis of vision and insights into the processes involved in retinal pathology. From a clinical point of view, there are two important questions arising from these developments: where do we stand today in finding disease-causing mutations in affected individuals, and what are the implications of this information for clinical practice? This perspective addresses these questions specifically for retinitis pigmentosa, but the observations apply generally to other forms of inherited eye disease.

Download full-text


Available from: Lori S Sullivan, Aug 30, 2015
1 Follower
  • Source
    • "stimulation of the lacrimal gland for treatment of dry eye syndrome [6] and treatment of obstructive sleep apnea [7], among many others. Retinal degenerative diseases, such as age-related macular degeneration (AMD) and retinitis pigmentosa, lead to blindness due to the loss of photoreceptors [8]–[10]. However, a significant number of the inner retinal neurons survive in such diseases [11]–[13], raising the possibility of sight restoration with electrical stimulation of the remaining inner retinal neurons. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Photovoltaic conversion of pulsed light into pulsed electric current enables optically-activated neural stimulation with miniature wireless implants. In photovoltaic retinal prostheses, patterns of near-infrared light projected from video goggles onto subretinal arrays of photovoltaic pixels are converted into patterns of current to stimulate the inner retinal neurons. We describe a model of these devices and evaluate the performance of photovoltaic circuits, including the electrode-electrolyte interface. Characteristics of the electrodes measured in saline with various voltages, pulse durations, and polarities were modeled as voltage-dependent capacitances and Faradaic resistances. The resulting mathematical model of the circuit yielded dynamics of the electric current generated by the photovoltaic pixels illuminated by pulsed light. Voltages measured in saline with a pipette electrode above the pixel closely matched results of the model. Using the circuit model, our pixel design was optimized for maximum charge injection under various lighting conditions and for different stimulation thresholds. To speed discharge of the electrodes between the pulses of light, a shunt resistor was introduced and optimized for high frequency stimulation.
    IEEE Transactions on Biomedical Circuits and Systems 01/2015; DOI:10.1109/TBCAS.2014.2376528 · 3.15 Impact Factor
  • Source
    • "Retinitis pigmentosa (RP) is the most common form of inherited retinal dystrophies (IRD) and is clinically and genetically heterogeneous. At least 50 genes have been identified for nonsyndromic RP [1] (RetNet; provided in the public domain by the University of Texas Houston Health Science Center, Houston, TX). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to gain information about disease prevalence and to identify the responsible genes for inherited retinal dystrophies (IRD) in Japanese populations. Clinical and molecular evaluations were performed on 349 patients with IRD. For segregation analyses, 63 of their family members were employed. Bioinformatics data from 1,208 Japanese individuals were used as controls. Molecular diagnosis was obtained by direct sequencing in a stepwise fashion utilizing one or two panels of 15 and 27 genes for retinitis pigmentosa patients. If a specific clinical diagnosis was suspected, direct sequencing of disease-specific genes, that is, ABCA4 for Stargardt disease, was conducted. Limited availability of intrafamily information and decreasing family size hampered identifying inherited patterns. Differential disease profiles with lower prevalence of Stargardt disease from European and North American populations were obtained. We found 205 sequence variants in 159 of 349 probands with an identification rate of 45.6%. This study found 43 novel sequence variants. In silico analysis suggests that 20 of 25 novel missense variants are pathogenic. EYS mutations had the highest prevalence at 23.5%. c.4957_4958insA and c.8868C>A were the two major EYS mutations identified in this cohort. EYS mutations are the most prevalent among Japanese patients with IRD.
    Journal of Ophthalmology 01/2015; 2015:819760. DOI:10.1155/2015/819760 · 1.94 Impact Factor
  • Source
    • "Inherited retinal diseases are among the leading causes for incurable vision loss in the human and canine populations [1]–[5]. In dogs, most of these conditions are classified as progressive retinal atrophy (PRA), and, similar to many forms of retinitis pigmentosa (RP) in human patients, primarily affect rod photoreceptors leading to initial night-vision loss followed by loss of cone photoreceptors and subsequent day-blindness [1], [3], [5]. Cone-rod dystrophies (crd) and primary cone degeneration (cd) have also been described in dogs with either combined initial day- and night-vision loss or exclusive day-blindness [1], [5]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Inherited retinal degenerations, such as retinitis pigmentosa (RP) and age-related macular degeneration (AMD), represent leading causes of incurable blindness in humans. This is also true in dogs, where the term progressive retinal atrophy (PRA) is used to describe inherited photoreceptor degeneration resulting in progressive vision loss. Because of the similarities in ocular anatomy, including the presence of a cone photoreceptor-rich central retinal region, and the close genotype-phenotype correlation, canine models contribute significantly to the understanding of retinal disease mechanisms and the development of new therapies. The screening of the pure-bred dog population for new forms of PRA represents an important strategy to establish new large animal models. By examining 324 dogs of the Swedish vallhund breed in seven countries and across three continents, we were able to describe a new and unique form of PRA characterized by the multifocal appearance of red and brown discoloration of the tapetal fundus followed over time by thinning of the retina. We propose three stages of the disease based on the appearance of the ocular fundus and associated visual deficits. Electroretinography revealed a gradual loss of both rod and cone photoreceptor-mediated function in Stages 2 and 3 of the disease. In the few dogs that suffered from pronounced vision loss, night-blindness occurred first in late Stage 2, followed by decreased day-vision in Stage 3. Histologic examinations confirmed the loss of photoreceptor cells at Stage 3, which was associated with the accumulation of autofluorescent material in the adjacent retinal pigment epithelium. Pedigree analysis was suggestive of an autosomal-recessive mode of inheritance. Mutations in six known canine retinal degeneration genes as well as hypovitaminosis E were excluded as causes of the disease. The observed variability in the age of disease onset and rate of progression suggest the presence of genetic and/or environmental disease modifiers.
    PLoS ONE 09/2014; 9(9):e106610. DOI:10.1371/journal.pone.0106610 · 3.23 Impact Factor
Show more